期刊文献+

九味霸咳汤治疗顽固性咳嗽的临床研究

Clinical Study on Treatment of Intractable Cough with Jiuwei Ba'ke Decoction
下载PDF
导出
摘要 目的:探讨九味霸咳汤干预ACEI类药物导致顽固性咳嗽的临床效果。方法:选择66例ACEI类药物导致顽固性咳嗽患者,随机分为九味霸咳汤治疗组(简称观察组)以及清燥救肺汤治疗组(简称对照组),治疗后观察两组患者咳嗽、咽部症状消失时间以及疗效,采用SF-36评价两组患者治疗后6个月的生活质量。结果:与对照组比较,观察组患者的咳嗽消失时间与咽部症状消失时间均降低明显,差异具有统计学意义(P<0.05)。观察组有效率96.97%优于对照组有效率81.82%,差异具有统计学意义(P<0.05)。与对照组比较,观察组患者各项生活质量指标均改变不明显,差异无统计学意义(P>0.05)。结论:九味霸咳汤可明显改善ACEI类药物导致顽固性咳嗽患者的临床症状,提高疗效。 Objective: To investigate the clinical effect of Jiuwei Ba’ke Decoction on intractable cough lead by ACEI drugs. Method:66 cases of patients with intractable cough lead by were randomly divided Jiuwei Ba’ke Decoction group (observation group) andDryness-clearing and Lung-rescuing Decoction group (control group). The cough,throat symptom disappearing time and curative effect ofthe two groups were observed. The life quality of patients in the two groups six months after the treatment was evaluated by SF-36. Results:Compared with the control group, the cough and throat symptoms disappearing time of the observation group were significantly reduced,and the difference was statistically significant (P 〈0.05). The effective rate of observation group was 96.97% which is higher than that(81.82%) of control group. The difference was statistically significant (P 〈0.05). Compared with the control group, the changes of lifequality indicators of observation group are not obvious, and the difference was not statistically significant (P〉 0.05). Conclusion: JiuweiBa’ke Decoction can significantly improve the clinical symptoms of patients with intractable cough lead by ACEI drugs and improve thecurative efficacy.
作者 谢依名
出处 《中医临床研究》 2014年第30期31-32,共2页 Clinical Journal Of Chinese Medicine
关键词 九味霸咳汤 顽固性咳嗽 ACEI类药物 疗效 Jiuwei Ba’ke Decoction Intractable cough ACEI drugs Curative effect
  • 相关文献

参考文献4

二级参考文献39

  • 1刘力生,龚兰生,王文,降压治疗预防卒中再发研究协作组.降压治疗对中国脑血管病患者脑卒中再发预防的多中心随机双盲对照临床研究[J].中华心血管病杂志,2005,33(7):613-617. 被引量:48
  • 2Maitland ML,Kasza KE, Karrison T, et al. Ambulatory monitoring detects sorafenib induced blood pressure elevations on the first day of treatment [ J]. Clin Cancer Res,2009,15(19) :6 250.
  • 3Da Cunha V, Tham DM, Martin McNulty B, et al. Enalapril attenuates angiotensin Ⅱ - induced atherosclerosis and vascular inflammation [ J]. Atherosclerosis, 2005,178 ( 1 ) :9.
  • 4Manning J, Vehaskari VM. Postnatal modulation of prenatally programmed hypertension by dietary Na and ACE inhibition [ J ]. Am J Physiol Regul Integr Comp Physiol, 2005,288 ( 1 ) : R80.
  • 5Schofield RS, Kline SE, Schmalfuss CM, et al. Early outcomes of a care coordination - enhanced telehome care program for elderly veterans with chronic heart failure [ J ]. Telemed J E Health, 2005,11 ( 1 ) : 20.
  • 6Ishani A, Weinhandl E, Zhao Z, et al. Angiotensin - converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction[ J].J Am Coll Cardiol,2005 , 4 5 ( 3 ) :391.
  • 7Shao Q, Ren B, Saini HK, et al. Sarcoplasmic reticulum Ca^2+ transport and gene expression in congestive heart failure are modified by imidapril treatment [ J ]. Am J Physiol Heart Circ Physiol,2005,288 (4) : H 1 674.
  • 8Srinivasan J, Jayadev S, Kumaran D, et al. Effect of losartan and enalapril on cognitive deficit caused by Goldblatt induced hypertension [ J ]. Indian J Exp Biol, 2005,43 (3) :241.
  • 9Barnett AH. Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study [ J ]. Acta Diabetol, 2005,42 ( Suppl 1 ) : S42.
  • 10Winer N, Folker dose ACE - A, Murphy JA, et al inhibitor/calcium Effect of fixed - channel blocker combination therapy vs. ACE - inhibitor monotherapy on arterial compliance in hypertensive patients with type 2 diabetes [ J ]. Prey Cardiol,2005,8 ( 2 ) : 87.

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部